Drug interaction

Glycyrrhetinic Acid Exhibits Strong Inhibitory Effects Towards UDP-Glucuronosyltransferase (UGT) 1A3 and 2B7.

Glycyrrhetinic Acid Exhibits Strong Inhibitory Effects Towards UDP-Glucuronosyltransferase (UGT) 1A3 and 2B7.

Filed under: Drug and Alcohol Rehabilitation

Phytother Res. 2012 Nov 12;
Huang YP, Cao YF, Fang ZZ, Zhang YY, Hu CM, Sun XY, Yu ZW, Zhu X,… Continue reading

Drug and Alcohol Rehabilitation: New Drug Development for Cognitive Enhancement in Mental Health: Challenges and Opportunities.

New drug development for cognitive enhancement in mental health: challenges and opportunities.

Filed under: Drug and Alcohol Rehabilitation

Neuropharmacology. 2013 Jan; 64: 2-7
Insel T, Krystal J, Ehlers M

HubMed – drug

 

Evaluating and managing patients with thyrotoxicosis.… Continue reading

Malcolm Bowden – Is Faith a Remedy for Depression?


 

Malcolm Bowden – Is faith a remedy for depression? – Malcolm Bowden is a Christian who believes that depression is not a real mental illness, but a manifestation of the cardinal sin of pride. Malcolm believes that true Christians… Continue reading

Depression Treatment: Treating Depression Within the HIV “Medical Home”: A Guided Algorithm for Antidepressant Management by HIV Clinicians.

Treating Depression Within the HIV “Medical Home”: A Guided Algorithm for Antidepressant Management by HIV Clinicians.

Filed under: Depression Treatment

AIDS Patient Care STDS. 2012 Nov; 26(11): 647-54
Adams JL, Gaynes BN, McGuinness T, Modi R, Willig J, Pence… Continue reading

Fexinidazole: A Potential New Drug Candidate for Chagas Disease.

Fexinidazole: a potential new drug candidate for chagas disease.

Filed under: Drug and Alcohol Rehabilitation

PLoS Negl Trop Dis. 2012 Nov; 6(11): e1870
Bahia MT, de Andrade IM, Martins TA, do Nascimento AF, Diniz Lde F, Caldas IS, Talvani… Continue reading

Drug and Alcohol Rehabilitation: A Randomized Phase II Trial of Vismodegib Versus Placebo With FOLFOX or FOLFIRI and Bevacizumab in Patients With Previously Untreated Metastatic Colorectal Cancer.

A Randomized Phase II Trial of Vismodegib Versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer.

Filed under: Drug and Alcohol Rehabilitation

Clin Cancer Res. 2012 Oct 18;
Berlin JD, Bendell JC,… Continue reading

Unexpected Neuronal Protection of SU5416 Against 1-Methyl-4-Phenylpyridinium Ion-Induced Toxicity via Inhibiting Neuronal Nitric Oxide Synthase.

Unexpected Neuronal Protection of SU5416 against 1-Methyl-4-Phenylpyridinium Ion-Induced Toxicity via Inhibiting Neuronal Nitric Oxide Synthase.

Filed under: Drug and Alcohol Rehabilitation

PLoS One. 2012; 7(9): e46253
Cui W, Zhang Z, Li W, Mak S, Hu S, Zhang H, Yuan… Continue reading

Drug and Alcohol Rehabilitation: The Laboratory and the New Oral Anticoagulants.

The Laboratory and the New Oral Anticoagulants.

Filed under: Drug and Alcohol Rehabilitation

Clin Chem. 2012 Oct 5;
Tripodi A

BACKGROUND:The new oral anticoagulants (NOAs) dabigatran, rivaroxaban, and apixaban have proved effective and safe when used in clinical trials,… Continue reading

BIOMARKERS of OPERATIONAL TOLERANCE in SOLID ORGAN TRANSPLANTATION.

BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION.

Filed under: Drug and Alcohol Rehabilitation

Expert Opin Med Diagn. 2012 Jul; 6(4): 281-293
Heidt S, Wood KJ

INTRODUCTION: Long-term immunosuppressive therapy represents a huge burden on transplant recipients, but currently… Continue reading

Rehab Centers: The Western Model of Integrative Oncology – the Contribution of Chinese Medicine.

The Western model of integrative oncology – the contribution of Chinese medicine.

Filed under: Rehab Centers

Chin J Integr Med. 2012 Sep; 18(9): 643-51
Dobos GJ, Kirschbaum B, Choi KE

Western integrative oncology (IO) combines conventional mainstream medicine with… Continue reading